Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo-Reference-Cited by-同舟云学术

Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo

Published:2023-10 Issue: Volume:574 Page:216395
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Schelch Karin,Emminger Dominik^ORCID,Zitta Benjamin,Johnson Thomas G.^ORCID,Kopatz Verena^ORCID,Eder Sebastian^ORCID,Ries Alexander^ORCID,Stefanelli Alessia^ORCID,Heffeter Petra^ORCID,Hoda Mir A.,Hoetzenecker Konrad,Dome Balazs,Berger Walter,Reid Glen^ORCID,Grusch Michael

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference54 articles.

1. Pleural mesothelioma classification update;Beasley;Virchows Arch.,2021

2. Epidemiology and clinical aspects of malignant pleural mesothelioma;Brims;Cancers,2021

3. The molecular basis of malignant pleural mesothelioma;Wadowski;Thorac. Surg. Clin.,2020

4. Scientific advances and new frontiers in mesothelioma therapeutics;Mutti;J. Thorac. Oncol.,2018

5. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial;Baas;Lancet,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer;Cancer Letters;2024-10

2. Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer;Frontiers in Immunology;2024-04-18

3. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer;Drug Resistance Updates;2024-03

4. Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential;International Journal of Molecular Sciences;2024-01-05

5. Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease;Cancers;2023-12-06